LabMedica

Download Mobile App
Recent News Expo ADLM 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Microfluidic Biosensors Developed for Diagnostic Devices

By Labmedica staff writers
Posted on 04 Apr 2007
A faster and cheaper microfluidic biosensor will allow companies to transfer their assays onto polymer microfluidic biosensor platforms, allowing development of point-of-use diagnostic devices.

Biosensor company Sensortec (Fort Wayne, IN, USA) and microfluidics specialist Minifab (Melbourne, Australia) are collaborating to provide a fast and low cost microfluidic biosensor development platform for R&D laboratories.

Sensortec technology provides a universally applicable electrochemical biosensor suitable for a whole range of diagnostic tests and other quantitative receptor-target binding assays requiring high analytic sensitivity. This biosensor technology has multiple applications and has already been evaluated for use in the environmental and food quality assurance sectors for detecting such contaminants as mycotoxins and drug residues.

Using micro- and nano-engineering, the MiniChemLab family of systems is an integrated platform to be used by biosensor assay developers wishing to optimize system specifications to realize commercial point-of-use diagnostic instrumentation.

Minifab CEO, Erol Harvey, said, "We have been impressed at the robustness and great sensitivity of the low cost biosensor technology. The simplicity of the electrochemical sensor easily allows it to be integrated into our polymer microfluidic systems.”

Commenting on why Sensortec has chosen Minifab to work with, Duncan Purvis said, "Minifab has a well demonstrated rapid-prototyping technology for polymer microfluidics which easily translates into low-cost high-volume production.”


Related Links:
Sensortec
Minifab

Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
Prefilled Tubes
Prefilled 5.0ml Tubes
New
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240

Latest Industry News

Collaboration Advances Extracellular Vesicle-Based Tests for Neurodegenerative Diseases
04 Apr 2007  |   Industry

Tempus to Acquire Personalis in $1.5 Billion Precision Oncology Deal
04 Apr 2007  |   Industry

Bruker Expands NGS Capabilities for Sepsis and Bloodstream Infections
04 Apr 2007  |   Industry



PURITAN MEDICAL